Acute Disseminated Encephalomyelitis : A rare form of COVID-19's neurotropism

© 2021 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd..

INTRODUCTION: the COVID-19 pandemic still accounts for thousands of cases every day. It's neurological involvement has been well documented most likely due to auto-immune mechanisms than the virus itself.

CASE REPORT: we report the case of a 38 years old women who developed an Acute Disseminated Encephalomyelitis following a COVID-19 infection, with a favorable outcome after immunosuppressive therapy.

DISCUSSION: In this chapter, we discuss ADEM's pathogenesis as well as its clinical and radiological features before detailing its relationship with infectious and vaccination episodes. We also discuss how our patient disease evolved.

CONCLUSION: Acute Disseminated Encephalomyelitis is an immune-mediated disorder in which the widespread inflammation of the brain and spinal cord is responsible for a variety of symptoms. The novel COVID-19 virus and its vaccine are both a newly incriminated etiologies of this demyelinating disorder.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:71

Enthalten in:

Annals of medicine and surgery (2012) - 71(2021) vom: 11. Nov., Seite 102940

Sprache:

Englisch

Beteiligte Personen:

Berrichi, Samia [VerfasserIn]
Bouayed, Zakaria [VerfasserIn]
Berrajaa, Sara [VerfasserIn]
Bahouh, Choukri [VerfasserIn]
Oulalite, Amine Mohammed [VerfasserIn]
Douqchi, Badie [VerfasserIn]
Bella, Islam [VerfasserIn]
Bkiyar, Houssam [VerfasserIn]
Housni, Brahim [VerfasserIn]

Links:

Volltext

Themen:

ADEM
COVID-19
Case Reports
Neurotropism

Anmerkungen:

Date Revised 27.04.2022

published: Print-Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.1016/j.amsu.2021.102940

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM332001490